Your browser doesn't support javascript.
loading
Eruptive naevi associated with encorafenib for metastatic colorectal cancer: two cases.
Alfallouji, Yasmin; Spencer, Ashley; Calonje, Eduardo; Perrett, Conal M; Watchorn, Richard; Borysiewicz, Catherine; Hodgkinson, Tara; Wasan, Harpreet; Bunker, Christopher B; Sidwell, Rachel U.
Afiliação
  • Alfallouji Y; University College London Hospital NHS Trust, London, UK.
  • Spencer A; Imperial College NHS Trust, London, UK.
  • Calonje E; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Perrett CM; University College London Hospital NHS Trust, London, UK.
  • Watchorn R; The Devonshire Clinic, London, UK.
  • Borysiewicz C; Imperial College NHS Trust, London, UK.
  • Hodgkinson T; Imperial College NHS Trust, London, UK.
  • Wasan H; Imperial College NHS Trust, London, UK.
  • Bunker CB; Imperial College NHS Trust, London, UK.
  • Sidwell RU; University College London Hospital NHS Trust, London, UK.
Clin Exp Dermatol ; 47(10): 1857-1858, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35633107
ABSTRACT
Encorafenib is a BRAF inhibitor increasingly used as a second-line treatment for metastatic melanoma and colorectal cancer. BRAF inhibitors have been reported to be associated with new and changing melanocytic lesions, including eruptive naevi. We describe two cases of eruptive naevi secondary to encorafenib used for the treatment of BRAF-mutant metastatic colorectal cancer.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Cutâneas / Neoplasias do Colo / Exantema / Nevo Pigmentado Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Neoplasias Cutâneas / Neoplasias do Colo / Exantema / Nevo Pigmentado Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Exp Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido